Publicaciones científicas
Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma
Farsaneh Sadeghlar 1, Julia Seelemann 1, Annabelle Vogt 1, Christian Möhring 1, Taotao Zhou 1, Robert Mahn 1, Miroslaw Kornek 1, Veronika Lukacs-Kornek 2, Noelia Casares 3, Juan José Lasarte 3, Pablo Sarobe 3, Cornelius van Beekum 3, Hanno Matthaei 4, Steffen Manekeller 4, Jörg Kalff 4, Ingo G H Schmidt-Wolf 1 5, Christian P Strassburg 1, Maria A Gonzalez-Carmona 1
Abstract
Background & aims: Vaccination with tumor-associated antigen-pulsed dendritic cells leads to specific T-cell response against hepatocellular carcinoma. However, clinical response has been shown to be limited. High regulatory T-cell count is associated with poor prognosis and seems to mediate immune tolerance in hepatocellular carcinoma. Forkhead box P3-peptide inhibitor P60 has been shown to specifically inhibit regulatory T-cell function in murine models. Aim of this study was to investigate whether P60 can improve the immune response induced by vaccination with adenovirus-transduced dendritic cells expressing alpha-fetoprotein in subcutaneous and orthotopic murine models for hepatocellular carcinoma.
Methods: Mice developing subcutaneous or orthotopic HCC received daily treatment with P60 starting at different tumor stages. Additionally, mice were vaccinated twice with dendritic cells expressing alpha-fetoprotein.
Results: In a preventive setting prior to tumor engraftment, vaccination with alpha-fetoprotein-expressing dendritic cells significantly decreased tumor growth in a subcutaneous model (p = .0256), but no further effects were achieved by addition of P60. However, P60 enhanced the antitumoral effect of a vaccination with alpha-fetoprotein-expressing dendritic cells in established subcutaneous and orthotopic hepatocellular carcinoma characterized by high Treg levels (p = .011).
Conclusion: In this study, we showed that vaccination with alpha-fetoprotein-expressing dendritic cells in combination with a specific inhibition of regulatory T-cells by using P60 leads to synergistic tumor inhibition and prolonged survival. This emphasizes the importance of regulatory T-cells inhibition for obtaining an effective antitumoral immune response in hepatocellular carcinoma.
CITA DEL ARTÍCULO Immunol Invest. 2023 Nov;52(8):966-984. doi: 10.1080/08820139.2023.2261980. Epub 2023 Nov 24.
Nuestros autores
